✦ LIBER ✦

Clinical trial simulation of docetaxel in patients with cancer as a tool for dosage optimization

✍ Scribed by Veyrat-Follet, C

Book ID: 111726861
Publisher: Nature Publishing Group
Year: 2000
Tongue: English
Weight: 116 KB
Volume: 68
Category: Article
ISSN: 0009-9236
DOI: 10.1067/mcp.2000.111948

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of docetaxel (Taxotere®

A phase II trial of docetaxel (Taxotere®) as second-line chemotherapy in patients with metastatic breast cancer

✍ Martina Baur; Allan T. van Oosterom; Véronique Diéras; Michele Tubiana-Hulin; R. 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 385 KB

Phase 2 study of neoadjuvant docetaxel p

Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer : A Prostate Cancer Clinical Trials Consortium trial

✍ Robert W. Ross; Matthew D. Galsky; Phil Febbo; Marc Barry; Jerome P. Richie; Wan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB

Optimal design of clinical trials with c

Optimal design of clinical trials with computer simulation based on results of earlier trials, illustrated with a lipodystrophy trial in HIV patients

✍ Ismail Abbas; Joan Rovira; Josep Casanovas; Tony Greenfield 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 231 KB

Randomized Phase III Trial of Erlotinib

Randomized Phase III Trial of Erlotinib Versus Docetaxel As Second- or Third-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA)

✍ Kawaguchi, T.; Ando, M.; Asami, K.; Okano, Y.; Fukuda, M.; Nakagawa, H.; Ibata, 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 183 KB

Phase II trial of docetaxel in patients

Phase II trial of docetaxel in patients with recurrent malignant glioma: a study of the National Cancer Institute of Canada Clinical Trials Group

✍ Peter Forsyth; Greg Cairncross; David Stewart; Michael Goodyear; Nancy Wainman; 📂 Article 📅 1996 🏛 Springer US 🌐 English ⚖ 330 KB

A phase II trial of docetaxel and erloti

A phase II trial of docetaxel and erlotinib as first-line therapy for elderly patients with androgen-independent prostate cancer

✍ Mitchell Gross; Celestia Higano; Allan Pantuck; Olga Castellanos; Erica Green; K 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 278 KB